Neoadjuvant hormone therapy before salvage radiotherapy for an increasing post-radical prostatectomy serum prostate specific antigen level.

MLA

Tiguert, Rabi, et al. “Neoadjuvant Hormone Therapy before Salvage Radiotherapy for an Increasing Post-Radical Prostatectomy Serum Prostate Specific Antigen Level.” The Journal of Urology, vol. 170, no. 2 Pt 1, Aug. 2003, pp. 447–50. EBSCOhost, https://doi.org/10.1097/01.ju.0000075351.51838.b3.

APA

Tiguert, R., Rigaud, J., Lacombe, L., Laverdière, J., & Fradet, Y. (2003). Neoadjuvant hormone therapy before salvage radiotherapy for an increasing post-radical prostatectomy serum prostate specific antigen level. The Journal of Urology, 170(2 Pt 1), 447–450. https://doi.org/10.1097/01.ju.0000075351.51838.b3

Chicago

Tiguert, Rabi, Jérôme Rigaud, Louis Lacombe, Jacques Laverdière, and Yves Fradet. 2003. “Neoadjuvant Hormone Therapy before Salvage Radiotherapy for an Increasing Post-Radical Prostatectomy Serum Prostate Specific Antigen Level.” The Journal of Urology 170 (2 Pt 1): 447–50. doi:10.1097/01.ju.0000075351.51838.b3.